| Literature DB >> 32792602 |
Xiayu Xu1,2, Fei Sun3, Qiong Wang3, Maiye Zhang3, Wenxiang Ding1,2, Aili Yang4, Bin Gao5.
Abstract
To examine the association between various retinal vascular measurements and microalbuminuria in patients with type 2 diabetes in a northwestern China study. Data from 911 patients with type 2 diabetes were analyzed. Novel retinal vascular measurements from the whole vascular tree were extracted using a validated fully automatic computer program. Retinal vascular measurements were analyzed continuously and categorically for associations with microalbuminuria using multiple logistic regressions, adjusted for related variables. In logistic regression adjusting for multiple variables, microalbuminuria was associated with smaller peripheral arteriolar caliber, larger peripheral venular caliber, larger arteriolar tortuosity, and smaller arteriolar fractal dimension (p = 0.028, p < 0.001, p = 0.038, p = 0.035, respectively). In further categorical analyses, microalbuminuria was related to smaller peripheral arteriolar caliber [T1 vs. T3: odds ratio (OR) 2.029; 95% confidence interval (CI) 1.186-3.473], larger peripheral venular caliber (T1 vs. T3: OR 0.609; 95% CI 0.362-1.024), and smaller arteriolar fractal dimension (T1 vs. T3: OR 1.659; 95% CI 1.028-2.675). Microalbuminuria in type 2 diabetes is associated with both retinal vascular caliber and geometry. These noninvasive vascular measurements serve as potential preclinical markers to identify populations at high risk of early kidney disease in the course of diabetes.Entities:
Mesh:
Year: 2020 PMID: 32792602 PMCID: PMC7426409 DOI: 10.1038/s41598-020-70408-0
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Sample image showing the vascular caliber measurements. Centered at the optic disc, blood vessels were categorized into three concentric zones: central zone (0.5–1.0 DD), middle zone (1.0–2.0 DD), and peripheral zone (> 2.0 DD). The averaged arteriolar and venular calibers were calculated in each zone and denoted as aCtr, aMdl, aPeri, vCtr, vMdl, and vPeri, respectively.
Demographic and clinical baseline characteristics of the study subjects.
| All | Microalbuminuria | |||
|---|---|---|---|---|
| (n = 911) | Absent | Present | ||
| Men (%) | 70.7 | 70.0 | 73.1 | 0.402 |
| Age (years) | 49.61 ± 10.31 | 49.35 ± 10.11 | 50.55 ± 10.98 | 0.049 |
| Duration (years) | 6.62 ± 5.78 | 6.20 ± 5.60 | 8.12 ± 6.19 | < 0.001 |
| Smoking (%) | 47.6 | 47.9 | 46.7 | 0.766 |
| Body mass index (kg/m2) | 25.81 ± 3.44 | 25.63 ± 3.51 | 26.47 ± 3.10 | 0.001 |
| SBP (mmHg) | 126.44 ± 15.84 | 123.92 ± 14.30 | 135.61 ± 17.73 | < 0.001 |
| DBP (mmHg) | 79.53 ± 10.20 | 78.58 ± 9.65 | 82.99 ± 11.37 | < 0.001 |
| HbA1c (%) | 8.90 ± 2.25 | 8.85 ± 2.28 | 9.07 ± 2.10 | 0.073 |
| Total cholesterol (mmol/L) | 4.07 ± 1.01 | 4.07 ± 0.99 | 4.06 ± 1.06 | 0.997 |
| Triglyceride (mmol/L) | 2.03 ± 1.79 | 1.96 ± 1.71 | 2.30 ± 2.00 | 0.008 |
| HDL (mmol/L) | 0.96 ± 0.24 | 0.97 ± 0.24 | 0.93 ± 0.23 | 0.169 |
| LDL (mmol/L) | 2.39 ± 0.93 | 2.40 ± 0.90 | 2.36 ± 1.04 | 0.535 |
| Geometry measurements | ||||
| 0.46 ± 0.05 | 0.46 ± 0.05 | 0.46 ± 0.06 | 0.319 | |
| 0.55 ± 0.06 | 0.55 ± 0.05 | 0.56 ± 0.06 | 0.163 | |
| 1.44 ± 0.02 | 1.44 ± 0.02 | 1.43 ± 0.02 | < 0.001 | |
| 1.45 ± 0.02 | 1.45 ± 0.02 | 1.45 ± 0.02 | 0.111 | |
| Caliber measurements | ||||
| 43.25 ± 3.08 | 43.34 ± 2.99 | 42.92 ± 3.39 | 0.287 | |
| 41.50 ± 3.27 | 41.52 ± 3.26 | 41.43 ± 3.34 | 0.657 | |
| 38.33 ± 3.21 | 38.37 ± 3.09 | 38.17 ± 3.60 | 0.326 | |
| 47.53 ± 2.25 | 47.49 ± 2.20 | 47.67 ± 2.44 | 0.208 | |
| 42.20 ± 2.73 | 42.10 ± 2.67 | 42.56 ± 2.95 | 0.110 | |
| 38.78 ± 2.54 | 38.63 ± 2.40 | 39.33 ± 2.95 | 0.015 | |
Continuous variables are given as mean ± SD.
MBI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.
Adjusted odds ratios of microalbuminuria in relation to retinal vascular measurements as continuous variables.
| Microalbuminuria | ||||
|---|---|---|---|---|
| Model 1* | Model 2** | |||
| OR (95% CI) | OR (95% CI) | |||
| Geometry measurements | ||||
| 11.703 (0.671,204.053) | 0.092 | 32.733 (1.217,880.629) | 0.038 | |
| 18.860 (1.249,284.667) | 0.034 | 7.837 (0.358,171.715) | 0.191 | |
| 0.062 (0.015,0.249) | < 0.001 | 0.187 (0.039,0.886) | 0.035 | |
| 0.420 (0.109,1.620) | 0.208 | 0.556 (0.114,2.700) | 0.466 | |
| Caliber measurements | ||||
| 0.935 (0.885,0.988) | 0.016 | 0.954 (0.895,1.016) | 0.139 | |
| 0.945 (0.895,0.999) | 0.047 | 0.960 (0.903,1.020) | 0.185 | |
| 0.907 (0.852,0.965) | 0.002 | 0.924 (0.861,0.992) | 0.028 | |
| 1.063 (0.983,1.151) | 0.127 | 1.057 (0.967,1.155) | 0.225 | |
| 1.113 (1.034,1.199) | 0.004 | 1.087 (0.972,1.149) | 0.194 | |
| 1.183 (1.096,1.278) | < 0.001 | 1.180 (1.080,1.290) | < 0.001 | |
*Model 1 adjusted for age and sex.
**Model 2 adjusted for age, sex, duration, smoking, BMI, HbA1c, SBP, DBP, total cholesterol, triglyceride, high-density and low-density lipoprotein.
†Arteriolar caliber measurements were further adjusted for vCtr, vMdl, and vPeri.
‡Venular caliber measurements were further adjusted for aCtr, aMdl, and aPeri.
Adjusted odds ratio of microalbuminuria in relation to selected retinal vascular measurements in tertile.
| Model 1 | Model 2 | |||
|---|---|---|---|---|
| OR (95% CI) | OR (95% CI) | |||
| T1 (0.35–0.42) | 0.727 (0.489,1.081) | 0.115 | 0.724 (0.462,1.135) | 0.160 |
| T2 (0.43–0.46) | 0.817 (0.556,1.200) | 0.303 | 0.781(0.501,1.216) | 0.274 |
| T3 (0.47–0.71) | 1.00 | 1.00 | ||
| T1 (1.32–1.42) | 1.961 (1.297,2.964) | 0.001 | 1.659 (1.028,2.675) | 0.038 |
| T2 (1.43–1.45) | 1.248 (0.823,1.893) | 0.297 | 1.225 (0.765,1.961) | 0.398 |
| T3 (1.46–1.51) | 1.00 | 1.00 | ||
| T1 (36.79–45.41) | 2.200 (1.373,3.525) | 0.001 | 2.029 (1.186,3.473) | 0.010 |
| T2 (45.42–49.18) | 1.240 (0.808,1.901) | 0.325 | 1.406 (0.861,2.297) | 0.173 |
| T3 (49.19–61.68) | 1.00 | 1.00 | ||
| T1 (39.37–46.55) | 0.651 (0.417,1.015) | 0.058 | 0.609 (0.362,1.024) | 0.062 |
| T2 (46.56–49.15) | 0.420 (0.275,0.641) | < 0.001 | 0.426 (0.264,0.687) | < 0.001 |
| T3 (49.16–59.01) | 1.00 | 1.00 | ||
*Model 1 adjusted for age and sex;
**Model 2 adjusted for age, sex, duration, smoking, BMI, HbA1c, SBP, DBP, total cholesterol, triglyceride, high-density and low-density lipoprotein;
†Arteriolar caliber measurements were further adjusted for vCtr, vMdl, and vPeri.
‡Venular caliber measurements were further adjusted for aCtr, aMdl, and aPeri.